The American Cancer Society Cancer Action Network (ACS CAN), Friends of Cancer Research (FOCR), and the National Organization for Rare Disorders (NORD) along with more than 100 advocacy groups representing millions of patients submitted a letter to Members of the House of Representatives strongly opposing the Senate Right-to-Try Act (S. 204).
Washington, D.C. – May 22, 2018 – The House of Representatives passed legislation today that, if signed into law, will create a process for accessing experimental drugs without including proper patient protections. The Senate Right-to-Try legislation (S.
Washington, D.C. - Leading health care companies and organizations representing patients, providers, laboratories and diagnostic manufacturers called on Senate and House leaders to advance legislation that would reform and modernize the process for bringing innovative diagnostics
I am gravely concerned about a bill being considered by the Minnesota legislature that would add unnecessary challenges to the mountain cancer patients have to climb.
More than 100 organizations representing millions of patients, providers and consumers joined together in letters and formal comments to Congressional leadership and federal agencies urging the withdrawal of a proposed rule on short-term, limited duration insurance plans (STLD).
oday the American Cancer Society Cancer Action Network (ACS CAN) submitted comments to the Department of Health and Human Services (HHS) on proposed changes to rules governing short-term, limited duration insurance plans (STLD). The comments detail how the proposed rule could divide the individual insurance market and significantly weaken patient protections, leaving cancer patients and survivors with few meaningful or affordable coverage choices.
The U.S. House of Representatives today passed an FY 18 federal budget, which includes; a $3 billion increase for medical research at the National Institutes of Health (NIH)—the largest such funding increase in 15 years; and a $275 million increase for the National Cancer Institute (NCI).
Twenty organizations representing millions of patients and consumers across the country sent a letter to the Secretaries of Health and Human Services, Labor and Treasury urging the administration to address patient concerns before finalizing troubling rules that as currently drafted would undermine access to affordable, comprehensive health coverage.
The American Cancer Society Cancer Action Network (ACS CAN) submitted comments to the Department of Labor regarding proposed changes to rules governing association health plans (AHPs). The comments detail several ways the proposed rule could divide the individual insurance market and significantly weaken patient protections leaving cancer patients and survivors with few meaningful or affordable coverage choices.
ACS CAN together with a dozen patient groups sent a letter to Health and Human Services Secretary Alex Azar today urging clarification that allowing health plans to be sold that would essentially discriminate against older and sicker individuals would violate numerous requirements of the health care law.